February 12, 2026

Anbio Biotechnology (NNNN) Stock Analysis: Navigating a Complex Landscape in Medical Diagnostics

Anbio Biotechnology (NNNN), a promising player in the healthcare sector, operates within the medical instruments and supplies industry. Headquartered in Frankfurt am Main, Germany, this biotech company has carved out..

Cidara Therapeutics, Inc. (CDTX) Stock Report: Analyzing the Biotechnology Firm’s Current Valuation and Future Outlook

Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands out in the biotechnology landscape with a focus on developing targeted therapies for life-threatening diseases. Despite a robust market cap of $6.96 billion, the..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Uncovering a 45% Potential Upside

ZoomInfo Technologies Inc. (NASDAQ: GTM) stands as a dynamic player within the technology sector, specifically in the software application industry. With a focus on providing go-to-market intelligence and engagement platforms,..

DocuSign, Inc. (DOCU) Stock Analysis: Potential Upside of 91.95% Sparks Investor Interest

DocuSign, Inc. (NASDAQ: DOCU), a leader in electronic signature solutions, continues to capture attention in the technology sector with its innovative products and substantial potential upside. The company’s current stock..

TotalEnergies SE (TTE) Stock Analysis: Evaluating Growth Potential Amid Market Trends

TotalEnergies SE (TTE), a French energy giant with a market cap of $166.48 billion, is making waves in the oil and gas integrated industry. As a multi-energy company, TotalEnergies produces..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Unveiling a Potential 301% Upside in Biotech

Gossamer Bio, Inc. (NASDAQ: GOSS), a San Diego-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at addressing pulmonary arterial hypertension (PAH). With..

AMTD Digital Inc. (HKD): Inside the 1,085.90% Revenue Growth and What It Means for Investors

AMTD Digital Inc. (HKD), a relatively new player in the technology sector, has been capturing attention with its astounding revenue growth of 1,085.90%. Despite this impressive figure, investors might find..

Immutep Limited (IMMP) Stock Analysis: A 240% Potential Upside in Immunotherapy Breakthrough

Immutep Limited (NASDAQ: IMMP), an innovative player in the biotechnology sector, is capturing the attention of investors with its ambitious focus on developing immunotherapies for cancer and autoimmune diseases. The..

Senseonics Holdings (SENS) Stock Analysis: Is a 145% Upside Within Reach?

Investors eyeing the healthcare sector might find Senseonics Holdings, Inc. (NYSE: SENS) an intriguing prospect, particularly with its impressive projected upside of 145.67%. Specializing in continuous glucose monitoring (CGM) systems,..

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Oncology Frontier with Promising Clinical Trials

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making significant strides in the precision oncology sector, focusing on therapies for RAS/MAPK pathway-driven cancers. With a market capitalization of $3.58..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Exploring a Potential 118.62% Upside in the Medical Devices Sector

SANUWAVE Health, Inc. (NASDAQ: SNWV), a promising player in the healthcare sector, particularly in the medical devices industry, is capturing the attention of investors with its innovative approach to regenerative..

Phathom Pharmaceuticals, Inc. (PHAT): Investor Outlook on an 87% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline in gastrointestinal therapeutics and an impressive potential upside..

Absci Corporation (ABSI) Stock Analysis: Exploring a 209% Upside Potential in Biotech Innovation

Absci Corporation (NASDAQ: ABSI) stands at the cutting edge of biotechnology, leveraging artificial intelligence to innovate in drug creation. Operating in the burgeoning healthcare sector, Absci is carving out a..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Unpacking a 230% Potential Upside in The Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), a company at the intersection of healthcare and technology, has been gaining attention for its innovative approach in the medical devices sector. Headquartered in Petah..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 307.96% Potential Upside in the Biotech Sector

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector due to its promising pipeline of gene and cell therapies and a compelling potential..

Alumis Inc. (ALMS) Investor Outlook: Biotech Innovator with a 45% Upside Potential

Alumis Inc. (NASDAQ: ALMS), a burgeoning force in the biotechnology sector, is drawing significant attention from investors with its promising pipeline of treatments for autoimmune disorders. As a clinical-stage biopharmaceutical..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Bold 67% Upside Potential

Investors with an eye on the biotechnology sector might find Entrada Therapeutics, Inc. (NASDAQ: TRDA) an intriguing prospect, with a potential upside of 67.12% based on current analyst ratings. This..

Zhengye Biotechnology (ZYBT) Stock Analysis: Can This Chinese Vaccine Maker Rebound from a 52-Week Low?

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Zhengye Biotechnology Holding L (ZYBT), a Chinese company focused on the development and sale of..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unpacking a Potential 94.89% Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling opportunity, driven by its substantial potential upside of 94.89%. As a clinical-stage biopharmaceutical..

Quantum-Si Incorporated (QSI) Investor Outlook: Exploring a Potential 158% Upside

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative approach to protein sequencing technology. As a life sciences company..

Search

Funds

February 12, 2026

Search

Funds

February 12, 2026

FTSE 100

Funds